1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Epithelial Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DeNardo, G; DeNardo, S; Lamborn, K; Miers, L; Natarajan, A; Richman, C; Yuan, A | 1 |
Cao, W; Carrasquillo, J; Konner, JA; Larson, SM; O'Donoghue, J; Old, LJ; Pandit-Taskar, N; Philips, MD; Smith-Jones, PM | 1 |
2 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Epithelial Neoplasms
Article | Year |
---|---|
Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers?
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Female; Heterocyclic Compounds, 1-Ring; Humans; Immunoglobulin G; Indium Radioisotopes; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Paclitaxel; Prostatic Neoplasms; Radioimmunotherapy; Time Factors | 2005 |
Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Transport, Active; Carrier Proteins; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Folate Receptors, GPI-Anchored; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Indium Radioisotopes; Iodine Radioisotopes; Male; Metabolic Clearance Rate; Mice; Mice, Nude; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Pilot Projects; Radiography; Radioimmunodetection; Radiopharmaceuticals; Receptors, Cell Surface; Tissue Distribution | 2008 |